Hepatitis C Challenge: Hep C Caring Ambassadors Program
HepC Choices

Published Articles

Articles Published by CAP-Hepatitis C & CAP-Hepatitis C Medical Team Authors

  • Hepatitis C: Current Standards of Care and Future Perspectives
    Robert G. Gish , M.D., California Pacific Medical Center
    Member, CAP-Hepatitis C Medical Brainstorming Team
    Hepatitis C affects approximately 4-5 million people in the United States with nearly 75% having long-term hepatitis C virus (HCV). Even with advances in treatment, about one half of patients will not achieve an SVR. Pegylated interferon and ribavirin combination therapy is currently the standard of care for the treatment of chronic hepatitis C. 
  • Future Therapies for Hepatitis C
    Jean-Michel Pawlotsky and Robert G Gish.* Antivir Ther. 2006;11(4):397-408. 
    *Member, CAP-Hepatitis C Medical Brainstorming Team
    Although pegylated interferon-a plus ribavirin has become the standard for treating chronic hepatitis C virus infection, a substantial number of patients do not tolerate therapy and require dose reduction or discontinuation, or do not respond to this combination therapy. Thus, new therapeutic options are needed. Read more.
  • The Hepatitis C Crisis
    St. John TM, Sandt L.
    Ethnicity and Disease. 2005 Spring;15(2 Suppl 2):S52-7. An estimated 170 million persons (3% of the world's population) are infected with the hepatitis C virus (HCV), and 3 to 4 million persons are newly infected each year. Of those infected, 70%-85% develop chronic viremia with the potential for devastating long-term sequelae, including chronic liver disease, cirrhosis, hepatic failure, and hepatocellular carcinoma. The passivity in the public health sector and in the medical community at large with respect to hepatitis C portends a myriad of societal, fiscal, and personal costs for the United States within the next two decades unless immediate actions are taken to intervene in the natural history of this emerging public health crisis.

To order a reprint of The Hepatitis C Crisis, email: lorren@hepcchallenge.org  

  • Donate1
  • Donate2
  • Donate3
  • Donate4
  • Donate6
  • Donate8
Give a gift in celebration
Give a gift in memory
Shop for Us

 

Follow Us on Facebook

 

HCV testing sites

Hepatitis C can show no symptoms until advanced liver damage develops.

register to attend this eventdownload flyer and map Join Us on FAcebook